Siphonochilus aethiopicus, a traditional remedy for the treatment of allergic asthma
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Asthma is a chronic inflammatory disease of the lungs, characterized by increased sensitivity to bronchoconstriction associated with infiltration of immune cells and mucus hyper secretion. In South Africa, the indigenous plant Siphonochilus aethiopicus, is used by traditional health practitioners to treat colds and flu, wheezing of the chest, coughs, influenza, sinus problems and mild asthma. In this study we aimed to investigate the potential anti-inflammatory and immune-modulating properties of S. aethiopicus in vitro. The dried and powdered S. aethiopicus plant material was extracted with organic solvents. The dried extracts were screened in vitro in the transcription response, NF-B and a cytokine assay. Significant activity was observed for organic extracts of the plant in these assays. This study provides evidence that S. aethiopicus has anti-inflammatory and immune-suppressing properties in vitro. These findings may support anecdotal accounts of its effectiveness against allergic asthma.
Abstract
Asthma is a chronic inflammatory disease of the lungs, characterized by increased sensitivity to bronchoconstriction associated with infiltration of immune cells and mucus hyper secretion. In South Africa, the indigenous plant Siphonochilus aethiopicus, is used by traditional health practitioners to treat colds and flu, wheezing of the chest, coughs, influenza, sinus problems and mild asthma. In this study we aimed to investigate the potential anti-inflammatory and immune-modulating properties of S. aethiopicus in vitro. The dried and powdered S. aethiopicus plant material was extracted with organic solvents. The dried extracts were screened in vitro in the transcription response, NF-B and a cytokine assay. Significant activity was observed for organic extracts of the plant in these assays. This study provides evidence that S. aethiopicus has anti-inflammatory and immune-suppressing properties in vitro. These findings may support anecdotal accounts of its effectiveness against allergic asthma.
참고문헌 (44)
- Barnes PJ, "Nuclear factor-kB-a pivotal transcription factor in chronic inflammatory diseases", New Engl J Med, 336, pp.1066~1071 (1997)
- Borel JF, "History of the discovery of cyclosporine and of its early pharmacological development", Wien Klin Wochenschr, 114, pp.433~437 (2002)
- Boschetto P, "Neutrophils and asthma", Eur Respir J Suppl, 6, pp.456s~459s (1989)
- Casale TB, "TNF-alpha is important in human lung allergic reactions", Am J Respir Cell Mol Biol, 15, pp.35~44 (1996)
- Eichhorn T, "P-glycoprotein and its inhibition in tumours by phytochemicals derived from Chinese herbs", J Ethnopharmacol, 141, pp.557~570 (2012)
- Elliott CL, "Nuclear factor-kappa B is essential for up-regulation of interleukin-8 expression in human amnion and cervical epithelial cells", Mol Hum Reprod, 7, pp.787~790 (2001)
- Faleschini MT, "Chemical profiling with cytokine stimulating investigations of Sutherlandia frutescens L. R. (Br.) (Fabaceae)", South African Journal of Botany (2013)
- Ghavami G, "Cheminformatics-based selection and synergism of herbal extracts with anticancer agents on drug resistance tumor cells-ACHN and A2780", CP cell lines, 2011, pp.41, 665~674
- Gibson PG, "Heterogeneity of airway inflammation in persistent asthma", Chest, 119, pp.1329~1336 (2001)
- Grilli M, "NF-kappa B, and Rel: participants in a multiform transcriptional regulatory system", Int Rev Cytol, 143, pp.1~62 (1993)
- Harada A, "Essential involvement of interleukin-8 (IL-8) in acute inflammation", J Leukoc Biol, 56, pp.559~564 (1994)
- Jacobi HH, "IL-8 and the activation of eosinophils and neutrophils following nasal allergen challenge", Int Arch Allergy Immunol, 116, pp.53~59 (1998)
- Khana MA, "Alternative approach for mitigation of Doxorubicin-induced cardiotoxicity using herbal agents", Curr Clin Pharmacol (2013)
- Karakurum M, "Hypoxic induction of interleukin-8 gene expression in human endothelial cells", J Clin Invest, 93, pp.1564~1570 (1994)
- Ko YC, "Elevated IL-8 level in the urine of patients with urinary tract infections", Infect Immun, 61, pp.1307~1314 (1993)
- Kulielka GL, "Interleukin-8 gene induction in the myocardium after ischaemia and reperfusion in vivo", J Clin Invest, 95, pp.89~103 (1995)
- Kunsch C, "NF-kappa B subunit-specific regulation of the interleukin-8 promoter", Mol Cell Biol, 13, pp.6137~6146 (1993)
- Lamblin C, "Bronchial neutrophilia in patients with noninfectious status asthmaticus", Am J Respir Crit Care Med, 157, pp.394~402 (1998)
- Lenardo MJ, "NF-kB: a pleiotropic mediator of inducible and tissue specific gene control", Cell, 58, pp.227~229 (1989)
- Liao F, "Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice", J Clin Invest, 94, pp.877~884 (1994)
- Lydyard P, "BIOS Instant Notes: Immunology" (2004), Taylor & Francis
- MacDowell AL, "Neutrophils in asthma", Curr Allergy Asthma Rep, 7, pp.464~468 (2007)
- Manna SK, "Interleukin-8 induces nuclear transcription factor-KB through a TRAF-6 dependent pathway", J Biol Chem, 280, pp.7010~7021 (2005)
- Matsusaka T, "Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8", Proc Natl Acad Sci U S A, 90, pp.10193~10197 (1993)
- Mukaida N, "Novel mechanism of glucocorticoid-mediated gene repression: nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression", J Biol Chem, 269, pp.13289~13295 (1994)
- Muller S, "Sesquiterpene lactones from Montanoa hibiscifolia that inhibit the transcription factor NF-kappa B", J Nat Prod, 67, pp.622~630 (2004)
- Nocker RE, "Interleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease", Int Arch Allergy Immunol, 109, pp.183~191 (1996)
- O'Gorman MRG, "Handbook of Human Immunology" (2008), CRC Press
- Oliveira IC, "Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by the NF-kappa B site", Mol Cell Biol, 14, pp.5300~5308 (1994)
- Parkin J, "An overview of the immune system", Lancet, 357, pp.1777~1789 (2001)
- Raduner S, "Alkylamides from Echinacea are a new class of cannabinomimetics", J Biol Chem, 281, pp.14192~14206 (2006)
- Saller R, "Multimorbidity and multi-target therapy with herbal drugs", Praxis, 101, pp.1637~1642 (2012)
- Sekido N, "Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8", Nature, 365, pp.654~657 (1993)
- Simone RE, "Lycopene inhibits NF-KB-mediated IL-8 expression and changes redox and PPARy signaling in cigarette smoke-stimulated macrophages", PLoS One, 6, pp.e19652~ (2011)
- Smith HR, "Inflammatory cells and eicosanoid mediators in subjects with late asthmatic responses and increases in airway responsiveness", J Allergy Clin Immunol, 89, pp.1076~1084 (1992)
- Spelman K, "Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators", Altern Med Rev, 11, pp.128~150 (2006)
- Sonoda Y, "Stimulation of interleukin-8 production by acidic polysaccharides from the root of Panax ginseng", Immunopharmacology, 38, pp.287~294 (1998)
- Tapsell LC, "Health benefits of herbs and spices: the past, the present, the future", Med J Aust, 185, pp.S4~S24 (2006)
- Teran LM, "Neutrophil influx and interleukin-8 release after segmental allergen or saline challenge in asthmatics", Int Arch Allergy Immunol, 107, pp.374~375 (1995)
- Uluıʂık D, "Effects of ginseng and echinacea on cytokine mRNA expression in rats", Scientific World Journal, 2012, pp.942025~ (2012)
- Van Staden J, "Ethnobotany in South Africa", J Ethnopharmacol, 119, pp.329~330 (2008)
- Van Wyk B-E, "Medicinal plants of South Africa" (1997), Briza Publications
- Yoshida A, "Role of NF-kappaB-mediated interleukin-8 expression in intraocular neovascularization", Invest Ophthalmol Vis Sci, 39, pp.1097~1106 (1998)
- Zidek Z, "Current status and challenges of cytokine pharmacology", Br J Pharmacol, 157, pp.342~361 (2009)